BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 8, 2001
View Archived Issues
Positive preliminary data obtained for frozen OrCel in Rx of venous leg ulcers
Read More
Chronogesic advances to phase III trials at Durect
Read More
CTD's orBec enters phase II for treatment of Crohn's disease
Read More
Aventis reviews progress over last nine months
Read More
Abgenix licenses rights to human antiproperdin monoclonal antibodies
Read More
Allergan and ExonHit to collaborate on new molecular targets
Read More
Enrollment commences in phase I/II Neoquin trial for early-stage bladder cancer
Read More
Vical receives HIV vaccine milestone payment
Read More
Icos starts human trials for PDE4 inhibitor IC-485
Read More
Positive phase IV results reported for Olux in mild to moderate body psoriasis
Read More
Icos acquires rights to resiniferatoxin for urological disorders
Read More
Oral pan-erbB tyrosine kinase inhibitor shows evidence of activity, good tolerance in phase I
Read More
Orally active taxane profiled at recent international cancer conference
Read More
Sepracor reviews third quarter progress
Read More
Optimal dose and schedule of administration determined for Apomine
Read More
Clinical evaluation of novel anticancer agent CT-2584 summarized at recent meeting
Read More
Trastuzumab-DM1 immunoconjugate heading for clinical testing next year
Read More
Novel cancer-related protein identified by Georgetown and NeoPharm
Read More
Second Oxxon pharmaccine enters clinical testing
Read More
Lead drug from Palatin exhibits preclinical efficacy in female sexual dysfunction
Read More
Chemokine IL-8 receptor antagonists claimed by GSK scientists
Read More
Japanese lab designs new compounds with selectivity for nicotinic alpha7 receptors
Read More
Prostaglandin derivatives with binding affinity for EP receptors and use thereof
Read More
Phenylpiperazine derivatives synthesized at SCRAS claimed for BPH, portal hypertension, cirrhosis
Read More
Novel series useful for hormone-dependent diseases and in hormone replacement therapy
Read More
Inhibitors of MEK potentially useful for proliferative disorders described in patent
Read More
Novel sigma-receptor ligands claimed for use in CNS, gastrointestinal and cardiovascular disorders
Read More